Exelixis, Inc. (EXEL)
56.89
+2.25
(+4.12%)
USD |
NASDAQ |
Sep 01, 16:00
56.72
-0.17
(-0.30%)
After-Hours: 20:00
Exelixis Net Income (Annual) : 782.57M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 782.57M |
| December 31, 2024 | 521.27M |
| December 31, 2023 | 207.76M |
| December 31, 2022 | 182.28M |
| December 31, 2021 | 231.06M |
| December 31, 2020 | 111.78M |
| December 31, 2019 | 321.01M |
| December 31, 2018 | 690.07M |
| December 31, 2017 | 153.86M |
| December 31, 2016 | -70.22M |
| December 31, 2015 | -161.74M |
| December 31, 2014 | -268.54M |
| December 31, 2013 | -244.76M |
| December 31, 2012 | -147.64M |
| December 31, 2011 | 75.70M |
| Date | Value |
|---|---|
| December 31, 2010 | -92.33M |
| December 31, 2009 | -139.56M |
| December 31, 2008 | -175.57M |
| December 31, 2007 | -111.02M |
| December 31, 2006 | -123.19M |
| December 31, 2005 | -94.81M |
| December 31, 2004 | -137.24M |
| December 31, 2003 | -94.77M |
| December 31, 2002 | -84.88M |
| December 31, 2001 | -71.19M |
| December 31, 2000 | -75.41M |
| December 31, 1999 | -18.72M |
| December 31, 1998 | -15.67M |
| December 31, 1997 | -11.50M |
| December 31, 1996 | -5.311M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| BioMarin Pharmaceutical, Inc. | 348.90M |
| Cytokinetics, Inc. | -784.96M |
| Emergent BioSolutions, Inc. | 52.60M |
| Gilead Sciences, Inc. | 8.51B |